Equity and representation in oncology clinical evidence for FDA-approved treatments and the impact of COVID-19
BackgroundPivotal clinical trials form the evidentiary foundation for FDA oncology drug approvals, yet persistent disparities in participant demographics may limit the generalizability and equity of cancer care. This study aimed to quantify demographic disparities in pivotal trials that supported FD...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2026-05-01
|
| Serie: | Frontiers in Oncology |
| Soggetti: | |
| Accesso online: | https://www.frontiersin.org/articles/10.3389/fonc.2026.1666497/full |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|